Allena Pharmaceuticals, Inc.
ALNAQ
Revenue
0.00
0.000.00%
-Assets
17.81M
▼-3.92M▼-18.04%
3 Months ChangeLiabilities
14.07M
▲3.95M▲39.09%
3 Months ChangeFree Cash Flow
-10.46M
▼-564.00k▼-5.70%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2022-09-07
Form 8-K
ID: 0000950170-22-018183
2022-09-02
Form 8-K
ID: 0001193125-22-237990
2022-08-24
Form 8-K
ID: 0000950170-22-017733
2022-08-15
Form 10-Q
ID: 0000950170-22-017398
2022-08-11
Form 8-K
ID: 0001193125-22-218012
2022-08-04
Form 8-K
ID: 0001193125-22-212577
2022-07-12
Form 8-K
ID: 0001193125-22-192011
2022-07-11
Form 8-K
ID: 0001193125-22-190954
2022-07-08
Form 8-K
ID: 0001193125-22-190576
2022-07-05
Form 8-K
ID: 0001193125-22-187535